[Form 3] Enlight Renewable Energy Ltd. Initial Statement of Beneficial Ownership
Rhea-AI Filing Summary
Enlight Renewable Energy Ltd. director Adi Leviatan filed an initial Form 3 detailing his equity holdings in the company. The filing shows stock options covering 143,553 ordinary shares with an exercise price of $27.33 per share, expiring on January 10, 2032.
He also holds 31,561 performance-based restricted share units and 31,561 ordinary shares directly. The RSUs and performance-based RSUs were granted on October 1, 2025 and vest in four annual tranches from October 1, 2026 through October 1, 2029, subject to continued service and achievement of Total Income, Revenues, and Adjusted EBITDA performance metrics.
Positive
- None.
Negative
- None.
Insights
Routine Form 3 showing CEO‑level equity grants and no trading.
This Form 3 from Enlight Renewable Energy Ltd. lists Adi Leviatan’s existing equity awards rather than new market transactions. It details options over 143,553 shares at an exercise price of $27.33 expiring in 2032, plus 31,561 RSUs and 31,561 ordinary shares held directly.
The footnotes show time-based RSUs and performance-based RSUs granted on October 1, 2025, vesting annually from 2026 to 2029. Performance awards depend on Total Income, Revenues, and Adjusted EBITDA versus internal forecasts, with partial vesting from 90% achievement. No buys or sells are reported, so this filing mainly clarifies Leviatan’s long-term, performance-linked exposure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Performance-Based RSUs | -- | -- | -- |
| holding | Ordinary shares, NIS 0.1 par value per share | -- | -- | -- |
Footnotes (1)
- Consists of 31,561 restricted share units granted on October 1, 2025, with 7,890 vesting on each of October 1, 2026, October 1, 2027, and October 1, 2028, and 7,891 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. Stock options were granted on October 1, 2025, with 35,888 vesting on each of October 1, 2026, October 1, 2027, and October 1, 2028, and 35,889 vesting on October 1, 2029. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 7,890 on each of October 1, 2026, 2027, and 2028, and 7,891 on October 1, 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
